Knowledge, Attitudes, and Practices Among Patients with Systemic Lupus Erythematosus Toward Disease Management and Biologic Therapy

References

• Zhang SQ, Han JW, Sun LD, et al. A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population. Rheumatol Int. 2011;31(2):227–231. doi:10.1007/s00296-009-1247-2
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang J, Zhang J, et al. Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations. Ann Rheum Dis. 2016;75(5):891–898. doi:10.1136/annrheumdis-2014-206367
   PubMed Web of Science ®Google Scholar
• Harvey PR, Gordon C. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges. BioDrugs. 2013;27(2):85–95. doi:10.1007/s40259-013-0015-8
   PubMed Web of Science ®Google Scholar
• Mok CC, Cheung MY, Ho LY, Yu KL, To CH. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus. 2008;17(12):1103–1107. doi:10.1177/0961203308094280
   PubMed Web of Science ®Google Scholar
• Maheswaranathan M, Eudy AM, Barr AC, et al. Association of health literacy and numeracy with lupus knowledge and the creation of the lupus knowledge assessment test. J Rheumatol. 2022;49(6):585–591. doi:10.3899/jrheum.210708
   PubMed Web of Science ®Google Scholar
• Katz P, Dall’Era M, Trupin L, et al. Impact of limited health literacy on patient-reported outcomes in systemic lupus erythematosus. Arthritis Care Res. 2021;73(1):110–119. doi:10.1002/acr.24361
   Web of Science ®Google Scholar
• Aldhamy H, Maniatopoulos G, McCune VL, Mansi I, Althaqafy M, Pearce MS. Knowledge, attitude and practice of infection prevention and control precautions among laboratory staff: a mixed-methods systematic review. Antimicrob Resist Infect Control. 2023;12(1):57. doi:10.1186/s13756-023-01257-5
   PubMed Web of Science ®Google Scholar
• Tahani B, Manesh SS. Knowledge, attitude and practice of dentists toward providing care to the geriatric patients. BMC Geriatr. 2021;21(1):399. doi:10.1186/s12877-021-02343-2
   PubMed Web of Science ®Google Scholar
• Grisaru-Tal S, Itan M, Klion AD, Munitz A. A new Dawn for eosinophils in the tumour microenvironment. Nat Rev Cancer. 2020;20(10):594–607. doi:10.1038/s41568-020-0283-9
   PubMed Web of Science ®Google Scholar
• Gomez A, Parodis I. Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature. Autoimmun Rev. 2022;21(11):103188. doi:10.1016/j.autrev.2022.103188
   PubMed Web of Science ®Google Scholar
• Zeng X, Chen Y. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Chin J Intern Med. 2020;1(3):172–185.
   Google Scholar
• Monte TCS, Mateo PF, Izquierdo MG, et al. An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences. Clin Rheumatol. 2023;42(5):1259–1265. doi:10.1007/s10067-023-06500-3
   PubMed Web of Science ®Google Scholar
• Sahebalzamani M, Farahani H, Jamarani MT, Faezi ST, Moradi K, Paragomi P. Effects of a continuous care model on patients’ knowledge and health-related quality of life in systemic lupus erythematosus. Rehabil Nurs. 2017;42(6):E9–E18. doi:10.1002/rnj.283
   PubMed Web of Science ®Google Scholar
• Waldron N, Brown S, Hewlett S, Elliott B, McHugh N, McCabe C. ‘It’s more scary not to know’: a qualitative study exploring the information needs of patients with systemic lupus erythematosus at the time of diagnosis. Musculoskeletal Care. 2011;9(4):228–238. doi:10.1002/msc.221
   PubMedGoogle Scholar
• Scalzi LV, Ballou SP, Park JY, Redline S, Kirchner HL. Cardiovascular disease risk awareness in systemic lupus erythematosus patients. Arthritis Rheum. 2008;58(5):1458–1464. doi:10.1002/art.23419
   PubMedGoogle Scholar
• Bin Haikel KA, Al Tulaihi B. Awareness of systemic lupus erythematosus among primary health care patients in Riyadh, Saudi Arabia. Saudi Med J. 2019;40(2):177–182. doi:10.15537/smj.2019.2.23920
   PubMed Web of Science ®Google Scholar
• Barton JL. Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence. 2009;3:335–344. doi:10.2147/ppa.s5835
   PubMed Web of Science ®Google Scholar
• Sloan M, Naughton F, Harwood R, et al. Is it me? The impact of patient-physician interactions on lupus patients’ psychological well-being, cognition and health-care-seeking behaviour. Rheumatol Adv Pract. 2020;4(2):rkaa037. doi:10.1093/rap/rkaa037
   PubMedGoogle Scholar
• Kim IJ, Kim HA, Suh CH, et al. Impact of childbearing decisions on family size of Korean women with systemic lupus erythematosus. J Korean Med Sci. 2016;31(5):729–734. doi:10.3346/jkms.2016.31.5.729
   PubMed Web of Science ®Google Scholar
• Phuti A, Hodkinson B, Tikly M, Schneider M. “The feeling of not being entitled to something”: fertility, pregnancy, and sexuality among women with systemic lupus erythematosus in South Africa. Scand J Rheumatol. 2020;49(3):214–220. doi:10.1080/03009742.2019.1657492
   PubMed Web of Science ®Google Scholar
• Ilchmann-Diounou H, Menard S. Psychological stress, intestinal barrier dysfunctions, and autoimmune disorders: an overview. Front Immunol. 2020;11:1823. doi:10.3389/fimmu.2020.01823
   PubMed Web of Science ®Google Scholar
• Moraleda V, Prados G, Martinez MP, Sanchez AI, Sabio JM, Miro E. Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus. Int J Rheum Dis. 2017;20(10):1541–1550. doi:10.1111/1756-185X.13081
   PubMed Web of Science ®Google Scholar
• Shen B, Tan W, Feng G, et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:270878. doi:10.1155/2013/270878
   PubMedGoogle Scholar
• Miyokawa R, Kivler C, Louie S, Godor D, Tan L, Kenyon N. Self-administered mepolizumab in the management of severe asthma: usability and patient acceptance. Patient Prefer Adherence. 2020;14:1669–1682. doi:10.2147/PPA.S227465
   PubMed Web of Science ®Google Scholar
• Ding Q, Shiltz D, Hossami D, Konieczny AM. The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States. Expert Rev Pharmacoecon Outcomes Res. 2022;22(8):1231–1241. doi:10.1080/14737167.2022.2117690
   PubMed Web of Science ®Google Scholar